ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 795

High Interobserver Agreement on Ultrasonographic Findings in Patients with Large Vessel Vasculitis

Andreas P. Diamantopoulos1, Julia Geiger2, Frode Lohne3, Geirmund Myklebust1 and Wolfgang A. Schmidt4, 1Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 2Department of Radiology, University Children's Hospital, Zurich, Switzerland, 3Unilabs Røntgen Kristiansand, Kristiansand, Norway, 4Rheumatology, Immanuel Krankenhaus, Berlin, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Large vessel vasculitis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Ultrasound has a high sensitivity and specificity regarding the diagnosis of giant cell arteritis (GCA). Ultrasound can also depict extracranial large vessel vasculitis (LVV) in both GCA and Takayasu arteritis (TA) patients. Until now, no studies have examined the inter-observer agreement of the ultrasonographic findings in LVV patients.

Hence, the aim of this study was to examine the inter-observer agreement of the ultrasound examination of temporal arteries and large vessels in LVV patients.

Methods

This study is a part of the MUSES project (Magnetic resonance angiography vs Ultrasonography in Systemic large vEssel vasculitiS), a prospective cross-sectional study. Patients who were diagnosed with LVV by ultrasound, MRA or CTA were identified and included in the study at the Department of Rheumatology, Hospital of Southern Norway Trust in Kristiansand from January 2014 to June 2014. One ultrasonographer experienced in the use of vascular ultrasound (APD) examined and recruited the LVV patients. The common temporal (TC), temporal parietal branch (TP), temporal frontal branch (TF), carotid (AC), subclavian (AS), vertebral (AV), axillary (AA) arteries, abdominal aorta (AAR) and ascending thoracic aorta (TAR) were scanned in all patients. Films of ultrasound evaluation of every artery both in longitudinal and transverse view (TAR-only longitudinal view) were recorded, and these data were surveyed by an expert on vascular ultrasound (WAS) who was blinded to clinical and laboratory data. To calculate the inter-observer agreement the Cohen’s kappa test has been used.

Results

Nineteen patients were included in this study [(9 males, 10 females, median age 65 (32-78)]. Eighteen patients were diagnosed with GCA and one with TA. Six patients had new onset LVV and 13 had long lasting [(mean disease duration 3.3 years, 95% CI 1.95-4.67)]. Median CRP was 5 mg/l (1-133) and ESR 25 mm/hr (4-112).

The inter-observer agreement for the various arteries was: TC 0.94 (95% CI 0.82-1.00), TP 0.94 (95% CI 0.83-1.00), TF 0.87 (95% CI 0.70-1.00), AC 0.67 (95% CI 0.45-0.89), AS 0.94 (95% CI 0.84-1.00), AV 0.84 (95% CI 0.54-1.00), AA 1.00, TAR 1.00. None of the patients had affection of the abdominal aorta on ultrasound examination.

Conclusion

Ultrasonographic findings of aorta, temporal and supraaortic arteries in patients with LVV appears to be highly reproducible and can be recorded in films for further evaluation.  Nonetheless, experience in the use of vascular ultrasound is required to achieve these promising results.


Disclosure:

A. P. Diamantopoulos,
None;

J. Geiger,
None;

F. Lohne,
None;

G. Myklebust,
None;

W. A. Schmidt,

Novartis Pharma AG,

2,

Mundipharma,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-interobserver-agreement-on-ultrasonographic-findings-in-patients-with-large-vessel-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology